Clinical trial · Observational
Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France
Gynecology Beyond Gender: Exploration and Identification of Potential Obstacles and Levers in France for Cervical Cancer Screening in Transgender Men, by Conducting an Opinion Survey in a Specific Population
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In France, cervical cancer screening is the subject of a national screening programme organized for all asymptomatic individuals aged 25 to 65 years with a cervix. The latter contributes greatly to the prevention and early treatment of this disease, whose public health challenge is recognized worldwide. One of the objectives of this programme is to reduce inequalities in access. Transgender men, i.e. individuals assigned to the female gender at birth but identifying with the male gender, are concerned by this screening as long as they still have a cervix, according to the same modalities as for cisgender women. However, they are often excluded from health care, including organized screening programs. Gender change in civil status is one of the obstacles. The provision of gynaecological care is sometimes inadequate. The lack of knowledge of health professionals and the problems of discrimination that transgender people may face reduce the chances of having equitable access. This survey aims to explore the perception that transgender men have of cervical cancer screening and to identify the challenges they face, the obstacles and the levers to access this prevention program.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Health Services for Transgender Persons | — | UNRESOLVED | — |
| Transgender Persons | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Survey questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- prevalence of transgender men who have ever been screened for cervical cancer in their lifetime
- timeFrame
- At study entry, basline (no follow-up)
- description
- answer yes to the question "Have you ever been screened for cervical cancer in your lifetime?"
Secondary outcomes (1)
- measure
- prevalence of transgender men who feel concerned about cervical cancer screening
- timeFrame
- At study entry, basline (no follow-up)
- description
- answer yes to the question "Do you feel personally involved in cervical cancer screening?"
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * transgender male (assigned female at birth but identifying as male) * aged 25 to 65 years * Having retained her cervix * Having had sex before. Exclusion Criteria: * Under 25 and over 65 * Not having retained his cervix * History of cancerous lesion of the cervix
References
Publications (0)
Data not yet available